US EditionBioPoly® Knee FDA-Approved Clinical Study is Now Published on ClinicalTrials.gov – Ortho Spine News
FORT WAYNE, IN – April 23, 2025 – BioPoly LLC, an innovator in orthopedic implant biomaterial technology, is pleased to announce that patient recruitment has commenced for its clinical study, BioPoly Partial Resurfacing Knee Implant IDE, now officially listed on ClinicalTrials.gov, the world’s leading clinical trial database. This FDA-approved randomized controlled trial aims to demonstrate the safety and effectiveness of the BioPoly® Partial Res
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
BioPoly® Knee FDA-Approved Clinical Study is Now Published on ClinicalTrials.gov – Ortho Spine News
FORT WAYNE, IN – April 23, 2025 – BioPoly LLC, an innovator in orthopedic implant biomaterial technology, is pleased to announce that patient recruitment has commenced for its clinical study, BioPoly Partial Resurfacing Knee Implant IDE, now officially listed on ClinicalTrials.gov, the world’s leading clinical trial database. This FDA-approved randomized controlled trial aims to demonstrate the safety and effectiveness of the BioPoly® Partial Res
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
